Aseracare Hospice 2820 West Market Street, Suite 110, Fairlawn, OH, 44333 | |
(330) 835-3813 |
News Archive
GeoVax Labs, Inc., an Atlanta-based biopharmaceutical firm developing vaccines to prevent and fight Human Immunodeficiency Virus (HIV) infections, announced today that it has entered into definitive agreements with certain institutional investors, pursuant to which the Company has agreed to sell shares of its Series A convertible preferred stock at an aggregate purchase price of approximately $2.2 million and Series A warrants to purchase up to an aggregate of 2,933,333 shares of GeoVax common stock with an exercise price of $1.00 per share and a term of five years.
Researchers at the University of Minnesota Medical School have been awarded a $6.6 million grant from the National Institute of Mental Health to develop a new medical device that can treat mental health disorders in a way that has never been done before using brain rhythms.
Glutamic acid may be one of the components responsible for the lower blood pressures of people with vegetable-rich diets, according to a study published today in Circulation: Journal of the American Heart Association. Glutamic acid is a major component of protein; vegetable protein contains higher levels of glutamic acid than animal protein.
Despite its proven success at preventing cancer, many adolescents are still not getting the HPV vaccine. A new study from the University of Colorado School of Medicine at the Anschutz Medical Campus shows that physicians' delivery and communication practices must improve to boost vaccination completion rates.
A new study of liver transplant centers confirms that non-Hispanic white patients get placed on liver transplant waitlists at disproportionately higher rates than non-Hispanic Black patients.
› Verified 6 days ago
Name | Aseracare Hospice |
---|---|
Location | 2820 West Market Street, Suite 110, Fairlawn, Ohio |
Hospice ID | 361624 |
Category | Freestanding Hospice |
Ownership Type | Proprietary - Corporation |
Profit Type | FOR PROFIT |
Accreditation Provider | Community Health Accreditation Partner (CHAP) |
SSA county code | 780 |
News Archive
GeoVax Labs, Inc., an Atlanta-based biopharmaceutical firm developing vaccines to prevent and fight Human Immunodeficiency Virus (HIV) infections, announced today that it has entered into definitive agreements with certain institutional investors, pursuant to which the Company has agreed to sell shares of its Series A convertible preferred stock at an aggregate purchase price of approximately $2.2 million and Series A warrants to purchase up to an aggregate of 2,933,333 shares of GeoVax common stock with an exercise price of $1.00 per share and a term of five years.
Researchers at the University of Minnesota Medical School have been awarded a $6.6 million grant from the National Institute of Mental Health to develop a new medical device that can treat mental health disorders in a way that has never been done before using brain rhythms.
Glutamic acid may be one of the components responsible for the lower blood pressures of people with vegetable-rich diets, according to a study published today in Circulation: Journal of the American Heart Association. Glutamic acid is a major component of protein; vegetable protein contains higher levels of glutamic acid than animal protein.
Despite its proven success at preventing cancer, many adolescents are still not getting the HPV vaccine. A new study from the University of Colorado School of Medicine at the Anschutz Medical Campus shows that physicians' delivery and communication practices must improve to boost vaccination completion rates.
A new study of liver transplant centers confirms that non-Hispanic white patients get placed on liver transplant waitlists at disproportionately higher rates than non-Hispanic Black patients.
› Verified 6 days ago
NPI Number | 1174560429 |
Organization Name | Hospice Preferred Choice, Inc. |
Address | 2820 W Market St Fairlawn, Ohio, 44333 |
Phone Number | (330)835-3813 |
News Archive
GeoVax Labs, Inc., an Atlanta-based biopharmaceutical firm developing vaccines to prevent and fight Human Immunodeficiency Virus (HIV) infections, announced today that it has entered into definitive agreements with certain institutional investors, pursuant to which the Company has agreed to sell shares of its Series A convertible preferred stock at an aggregate purchase price of approximately $2.2 million and Series A warrants to purchase up to an aggregate of 2,933,333 shares of GeoVax common stock with an exercise price of $1.00 per share and a term of five years.
Researchers at the University of Minnesota Medical School have been awarded a $6.6 million grant from the National Institute of Mental Health to develop a new medical device that can treat mental health disorders in a way that has never been done before using brain rhythms.
Glutamic acid may be one of the components responsible for the lower blood pressures of people with vegetable-rich diets, according to a study published today in Circulation: Journal of the American Heart Association. Glutamic acid is a major component of protein; vegetable protein contains higher levels of glutamic acid than animal protein.
Despite its proven success at preventing cancer, many adolescents are still not getting the HPV vaccine. A new study from the University of Colorado School of Medicine at the Anschutz Medical Campus shows that physicians' delivery and communication practices must improve to boost vaccination completion rates.
A new study of liver transplant centers confirms that non-Hispanic white patients get placed on liver transplant waitlists at disproportionately higher rates than non-Hispanic Black patients.
› Verified 6 days ago
Quality Measure | Provider Score | National Score |
---|---|---|
Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 88.3 | 98.3 |
Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 75.7 | 93.6 |
Patients who were checked for pain at the beginning of hospice care | 95.1 | 93.9 |
Patients who got a timely and thorough pain assessment when pain was identified as a problem | 89.5 | 77.7 |
Patients who were checked for shortness of breath at the beginning of hospice care | 98.1 | 97.3 |
Patients who got timely treatment for shortness of breath | 86.8 | 94.6 |
Patients taking opioid pain medication who were offered care for constipation | 91.7 | 93.3 |
News Archive
GeoVax Labs, Inc., an Atlanta-based biopharmaceutical firm developing vaccines to prevent and fight Human Immunodeficiency Virus (HIV) infections, announced today that it has entered into definitive agreements with certain institutional investors, pursuant to which the Company has agreed to sell shares of its Series A convertible preferred stock at an aggregate purchase price of approximately $2.2 million and Series A warrants to purchase up to an aggregate of 2,933,333 shares of GeoVax common stock with an exercise price of $1.00 per share and a term of five years.
Researchers at the University of Minnesota Medical School have been awarded a $6.6 million grant from the National Institute of Mental Health to develop a new medical device that can treat mental health disorders in a way that has never been done before using brain rhythms.
Glutamic acid may be one of the components responsible for the lower blood pressures of people with vegetable-rich diets, according to a study published today in Circulation: Journal of the American Heart Association. Glutamic acid is a major component of protein; vegetable protein contains higher levels of glutamic acid than animal protein.
Despite its proven success at preventing cancer, many adolescents are still not getting the HPV vaccine. A new study from the University of Colorado School of Medicine at the Anschutz Medical Campus shows that physicians' delivery and communication practices must improve to boost vaccination completion rates.
A new study of liver transplant centers confirms that non-Hispanic white patients get placed on liver transplant waitlists at disproportionately higher rates than non-Hispanic Black patients.
› Verified 6 days ago
Home Health Aides | 4 |
Counselors | 0.8 |
Medical Social Workers | 1 |
Registered Nurses | 4 |
Other Personnel | 5 |
Total Employees | 14.8 |
---|
News Archive
GeoVax Labs, Inc., an Atlanta-based biopharmaceutical firm developing vaccines to prevent and fight Human Immunodeficiency Virus (HIV) infections, announced today that it has entered into definitive agreements with certain institutional investors, pursuant to which the Company has agreed to sell shares of its Series A convertible preferred stock at an aggregate purchase price of approximately $2.2 million and Series A warrants to purchase up to an aggregate of 2,933,333 shares of GeoVax common stock with an exercise price of $1.00 per share and a term of five years.
Researchers at the University of Minnesota Medical School have been awarded a $6.6 million grant from the National Institute of Mental Health to develop a new medical device that can treat mental health disorders in a way that has never been done before using brain rhythms.
Glutamic acid may be one of the components responsible for the lower blood pressures of people with vegetable-rich diets, according to a study published today in Circulation: Journal of the American Heart Association. Glutamic acid is a major component of protein; vegetable protein contains higher levels of glutamic acid than animal protein.
Despite its proven success at preventing cancer, many adolescents are still not getting the HPV vaccine. A new study from the University of Colorado School of Medicine at the Anschutz Medical Campus shows that physicians' delivery and communication practices must improve to boost vaccination completion rates.
A new study of liver transplant centers confirms that non-Hispanic white patients get placed on liver transplant waitlists at disproportionately higher rates than non-Hispanic Black patients.
› Verified 6 days ago
Others | 8 |
Total Volunteers | 8 |
---|
News Archive
GeoVax Labs, Inc., an Atlanta-based biopharmaceutical firm developing vaccines to prevent and fight Human Immunodeficiency Virus (HIV) infections, announced today that it has entered into definitive agreements with certain institutional investors, pursuant to which the Company has agreed to sell shares of its Series A convertible preferred stock at an aggregate purchase price of approximately $2.2 million and Series A warrants to purchase up to an aggregate of 2,933,333 shares of GeoVax common stock with an exercise price of $1.00 per share and a term of five years.
Researchers at the University of Minnesota Medical School have been awarded a $6.6 million grant from the National Institute of Mental Health to develop a new medical device that can treat mental health disorders in a way that has never been done before using brain rhythms.
Glutamic acid may be one of the components responsible for the lower blood pressures of people with vegetable-rich diets, according to a study published today in Circulation: Journal of the American Heart Association. Glutamic acid is a major component of protein; vegetable protein contains higher levels of glutamic acid than animal protein.
Despite its proven success at preventing cancer, many adolescents are still not getting the HPV vaccine. A new study from the University of Colorado School of Medicine at the Anschutz Medical Campus shows that physicians' delivery and communication practices must improve to boost vaccination completion rates.
A new study of liver transplant centers confirms that non-Hispanic white patients get placed on liver transplant waitlists at disproportionately higher rates than non-Hispanic Black patients.
› Verified 6 days ago
Aseracare Hospice Location: 2820 West Market Street, Suite 110, Fairlawn, Ohio, 44333 Phone: (330) 835-3813 |